Navigation Links
PharmaNet Shares Expertise in Drug Development Outsourcing at the 2011 Partnerships in Clinical Trials Conference
Date:3/21/2011

PRINCETON, N.J., March 21, 2011 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of drug development services to the pharmaceutical, biotechnology, generic drug and medical device industries, announces its participation at the 19th Annual Partnerships in Clinical Trials Conference in Phoenix, Arizona from March 30 to April 1. PharmaNet and industry experts will discuss pertinent industry topics, including:

Thursday March 31

Impact of Reform on Biosimilar Drug Development

Dalvir Gill, Ph.D., President, Late Stage Development, PharmaNet and Greg Skalicky, Senior Vice President, Worldwide Business Development, PharmaNet

Proactive GCP Compliance and Quality Management Systems

Jeffrey P. McMullen, CEO, PharmaNet and John W. Hubbard, Ph.D., FCP, Senior Vice President Worldwide Head, Development Operations, Pfizer

Assess the Impact of Industry Consolidation on Change Management and Your Outsourcing Operational Model

Marisa Bower, Senior Director, Business Development, PharmaNet

Outsourcing Phase IV Observational Studies: A Different Animal?

Jeffrey Trotter, Executive Vice President, Phase IV Development, PharmaNet

Friday April 1

Challenges and Opportunities in the Global Arena in Pediatric Drug Development

Philippa Smit-Marshall, MBChB, FFPM, FICR, Vice President and General Manager of Pediatrics & Medical Sciences, PharmaNet; and Diane Hoffman, Associate Director, Clinical Research Pediatric Group, Johnson & Johnson

Conference attendees can learn more about PharmaNet's capabilities by visiting booth 901 in the exhibition hall where an international team of representatives will be available to discuss PharmaNet's expertise in helping clients reach their goal of delivering safe and effective therapeutics to patients.

About PharmaNet

PharmaNet, a recognized leader of global drug development services to the pharmaceutical, biotechnology, generic drug, and medical device industries, provides comprehensive capabilities in Phase I-IV clinical development, bioanalytical and bioequivalence services, regulatory, staffing, and therapeutic solutions. For the applied knowledge and intelligent solutions needed to accelerate drug development programs of all sizes around the world, PharmaNet works for you. For more information, please visit www.PharmaNet.com.

Contact: Anne-Marie Hess
Phone:   (609) 951-6842
E-mail:   ahess@pharmanet.com


'/>"/>
SOURCE PharmaNet Development Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dr. Jeffrey Freitag Appointed Chief Medical Officer of PharmaNet
2. PharmaNet and Anapharm Europe Formally End Joint Venture
3. Catherine Derasp Joins PharmaNet as Vice President, Clinical Operations
4. PharmaNets Technology Investments Translate to Enhanced Client Service in Its Phase I Clinics
5. PharmaNet Launches New Brand Identity at Upcoming Industry Conferences
6. PharmaNet Development Group Announces Observational Research Survey
7. Steven Leventer Joins PharmaNet Development Group as Vice President, Clinical Research Neuroscience
8. PharmaNet Development Group Symposia Crossing the Bridge from Preclinical to Clinical Studies to be Held February 2010 in Basel, Dusseldorf and Vienna
9. Jeffrey Trotter Joins Pharmanet Development Group as Executive Vice President, Phase IV Development
10. PharmaNet Development Group Management Participates in the 8th Annual Partnerships in Clinical Trials Conference in Rotterdam
11. Azopharma and PharmaNet Development Group Enter Preclinical Strategic Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... Jan 20, 2017 Research and Markets ... Market Trends, Opportunities, and Future" report to their offering. ... This research service ... trends, and technologies, and provides a snapshot of the key participants ... and forecasts are provided from 2016 to 2020. The market is ...
(Date:1/19/2017)... , Jan. 19, 2017 ... Summary GlobalData,s new report, "Germany Cataract Surgery Devices ... the Germany Cataract Surgery Devices market. The report provides ... and average prices (USD) within market segements - Phacoemulsification ... also provides company shares and distribution shares data for ...
(Date:1/19/2017)... Call and Webcast to Follow Vanda Pharmaceuticals Inc. (Vanda) ... for the fourth quarter of 2016 on Wednesday, February 15, 2017, ... ... ET on Wednesday, February 15, 2017, during which management will discuss ... corporate activities. To participate in the conference call, please dial 1-888-771-4371 ...
Breaking Medicine Technology:
(Date:1/23/2017)... ARLINGTON, VA (PRWEB) , ... ... ... Seafood Nutrition Partnership (SNP) has launched online education programs and resources at ... health and nutritional benefits of a seafood-rich diet. These resources have been ...
(Date:1/23/2017)... ... January 23, 2017 , ... “Some Infallible Characteristics of Christ”: a ... Characteristics of Christ” is the creation of published author, Rev. Dr. Robert W. Thomas, ... thirteen years, a preacher for over nineteen, a pastor for over fifteen years. He ...
(Date:1/22/2017)... (PRWEB) , ... January 22, 2017 , ... Phytocéane invites ... isolated from the rest of the world with ZANZIBAR MILKY CREAM. Inspired by the ... key ingredients like Virgin Coconut Oil and moisturizing vegetal coral to create this gentle, ...
(Date:1/22/2017)... ... 22, 2017 , ... "Photo Cloud allows FCPX users to add favorited photos ... complete ease," said Christina Austin - CEO of Pixel Film Studios. , To ... timeline. Presets include scenes with one, three, four or five focus points. There ...
(Date:1/21/2017)... ... January 21, 2017 , ... Caronlab Australia, an Australian company known for ... Show in Hilton Head, SC, where it benefited from outstanding meetings with major retail ... beauty and wellness products. At this trade show, the company had the chance to ...
Breaking Medicine News(10 mins):